DSN has partnered with Competitive Promotion Report (CPR) and IRI to create a series of exclusive reports. This article highlights the market performance of major brands in the pain category for both the internal and external analgesic segments.
In May 2014, Pfizer introduced Nexium 24HR, one of the top-selling acid blockers, over the counter in the United States.
DSN has partnered with Competitive Promotion Report and IRI to create a series of exclusive reports. This month the analysis explores the market trends around retailer margin and promotional spending in the first-aid category, looking at the major national brands in the drug channel, focusing particularly on the anti-itch (including calamine), ointments/ antiseptics and bandages (including gauze and cotton) categories.
The introduction of store-brand products over the past decade changed the competitive landscape in most categories, with year-over-year growth outpacing national brands.
As many retailers continue to expand the presence of store brand products because of the high retailer margin percent these products offer, it is important to pause and consider what is the optimal balance of national brands and store brand that will drive overall business results for the retailer.
The growth of store brands continues to outpace national brands. However, there is a role for both national brands and store brands at retail.
DSN has partnered with Competitive Promotion Report and IRI to create a series of exclusive reports that analyze the impact of trade promotion activity on core front-end merchandising categories.
DSN has partnered with Competitive Promotion Report and IRI to create a new series of exclusive reports that analyzes the impact of trade promotion activity on various front-end merchandising categories — DSN Promo Watch.